1. Home
  2. STOK vs CHCO Comparison

STOK vs CHCO Comparison

Compare STOK & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$36.13

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo City Holding Company

CHCO

City Holding Company

HOLD

Current Price

$119.90

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
CHCO
Founded
2014
1957
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
STOK
CHCO
Price
$36.13
$119.90
Analyst Decision
Strong Buy
Hold
Analyst Count
10
2
Target Price
$36.10
$132.50
AVG Volume (30 Days)
560.9K
69.4K
Earning Date
04-15-2026
04-22-2026
Dividend Yield
N/A
2.83%
EPS Growth
30.67
13.18
EPS
0.85
8.93
Revenue
$36,555,000.00
N/A
Revenue This Year
$430.19
$5.16
Revenue Next Year
N/A
$3.12
P/E Ratio
$42.08
$13.80
Revenue Growth
316.34
N/A
52 Week Low
$5.35
$102.22
52 Week High
$38.62
$133.59

Technical Indicators

Market Signals
Indicator
STOK
CHCO
Relative Strength Index (RSI) 64.73 36.28
Support Level $30.50 $117.09
Resistance Level $37.98 $123.70
Average True Range (ATR) 2.04 3.27
MACD 0.41 -0.67
Stochastic Oscillator 77.87 9.93

Price Performance

Historical Comparison
STOK
CHCO

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

Share on Social Networks: